The fentanyl-specific antibody FenAb024 can shield against carfentanil effects

The surge in opioid-related deaths, driven predominantly by fentanyl and its synthetic derivatives, has become a critical public health concern, which is particularly evident in the United States. While the situation is less severe in Europe, the European Monitoring Centre for Drugs and Drug Addicti...

Full description

Saved in:
Bibliographic Details
Main Authors: Urban, Katharina (Author) , Gkeka, Anastasia (Author) , Chandra, Monica (Author) , Greiner, Dennis (Author) , Pollich, Selina (Author) , Ruf, Sandra (Author) , Kelemen, Yosip (Author) , Sundermann, Tom R. (Author) , Pravetoni, Marco (Author) , Baehr, Carly (Author) , Stebbins, Erec (Author) , Papavasiliou, Nina (Author) , Verdi, Joseph P. (Author)
Format: Article (Journal)
Language:English
Published: 15 May 202
In: Toxicology letters
Year: 2024, Volume: 396, Pages: 1-10
ISSN:1879-3169
DOI:10.1016/j.toxlet.2024.03.008
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.toxlet.2024.03.008
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0378427424000559
Get full text
Author Notes:Katharina Urban, Anastasia Gkeka, Monica Chandra, Dennis Greiner, Selina Pollich, Sandra Ruf, Yosip Kelemen, Tom Sundermann, Marco Pravetoni, Carly Baehr, C. Erec Stebbins, F. Nina Papavasiliou, Joseph P. Verdi

MARC

LEADER 00000caa a2200000 c 4500
001 1908744073
003 DE-627
005 20241205220701.0
007 cr uuu---uuuuu
008 241115s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.toxlet.2024.03.008  |2 doi 
035 |a (DE-627)1908744073 
035 |a (DE-599)KXP1908744073 
035 |a (OCoLC)1475647443 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Urban, Katharina  |e VerfasserIn  |0 (DE-588)1193590329  |0 (DE-627)1672318661  |4 aut 
245 1 4 |a The fentanyl-specific antibody FenAb024 can shield against carfentanil effects  |c Katharina Urban, Anastasia Gkeka, Monica Chandra, Dennis Greiner, Selina Pollich, Sandra Ruf, Yosip Kelemen, Tom Sundermann, Marco Pravetoni, Carly Baehr, C. Erec Stebbins, F. Nina Papavasiliou, Joseph P. Verdi 
264 1 |c 15 May 202 
300 |b Illustrationen, Diagramme 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 6 April 2024, Version des Artikels 13 April 2024 
500 |a Gesehen am 15.11.2024 
520 |a The surge in opioid-related deaths, driven predominantly by fentanyl and its synthetic derivatives, has become a critical public health concern, which is particularly evident in the United States. While the situation is less severe in Europe, the European Monitoring Centre for Drugs and Drug Addiction reports a rise in drug overdose deaths, with emerging concerns about the impact of fentanyl-related molecules. Synthetic opioids, initially designed for medical use, have infiltrated illicit markets due to their low production costs and high potency, with carfentanil posing additional threats, including potential chemical weaponization. Existing overdose mitigation heavily relies on naloxone, requiring timely intervention and caregiver presence, while therapeutic prevention strategies face many access challenges. To provide an additional treatment option, we propose the use of a fentanyl-specific monoclonal antibody (mAb), as a non-opioid method of prophylaxis against fentanyl and carfentanil. This mAb shows protection from opioid effects in a pre-clinical murine model. mAbs could emerge as a versatile countermeasure in civilian and biodefense settings, offering a novel approach to combat opioid-associated mortality. 
650 4 |a Antibody-associated protection 
650 4 |a Carfentanil 
650 4 |a Fentanyl 
650 4 |a Monoclonal antibodies 
650 4 |a Opioid crisis 
650 4 |a Passive immunization 
700 1 |a Gkeka, Anastasia  |e VerfasserIn  |4 aut 
700 1 |a Chandra, Monica  |e VerfasserIn  |4 aut 
700 1 |a Greiner, Dennis  |e VerfasserIn  |4 aut 
700 1 |a Pollich, Selina  |e VerfasserIn  |4 aut 
700 1 |a Ruf, Sandra  |e VerfasserIn  |4 aut 
700 1 |a Kelemen, Yosip  |e VerfasserIn  |4 aut 
700 1 |a Sundermann, Tom R.  |d 1985-  |e VerfasserIn  |0 (DE-588)1065025017  |0 (DE-627)815431430  |0 (DE-576)424716364  |4 aut 
700 1 |a Pravetoni, Marco  |e VerfasserIn  |4 aut 
700 1 |a Baehr, Carly  |e VerfasserIn  |4 aut 
700 1 |a Stebbins, Erec  |d 1969-  |e VerfasserIn  |0 (DE-588)1263866867  |0 (DE-627)1811961134  |4 aut 
700 1 |a Papavasiliou, Nina  |e VerfasserIn  |0 (DE-588)1234989549  |0 (DE-627)1760001279  |4 aut 
700 1 |a Verdi, Joseph P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Toxicology letters  |d Amsterdam [u.a.] : Elsevier Science, 1977  |g 396(2024) vom: Mai, Seite 1-10  |h Online-Ressource  |w (DE-627)306710862  |w (DE-600)1500784-4  |w (DE-576)08243607X  |x 1879-3169  |7 nnas  |a The fentanyl-specific antibody FenAb024 can shield against carfentanil effects 
773 1 8 |g volume:396  |g year:2024  |g month:05  |g pages:1-10  |g extent:10  |a The fentanyl-specific antibody FenAb024 can shield against carfentanil effects 
856 4 0 |u https://doi.org/10.1016/j.toxlet.2024.03.008  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0378427424000559  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241115 
993 |a Article 
994 |a 2024 
998 |g 1234989549  |a Papavasiliou, Nina  |m 1234989549:Papavasiliou, Nina  |d 50000  |e 50000PP1234989549  |k 0/50000/  |p 12 
998 |g 1263866867  |a Stebbins, Erec  |m 1263866867:Stebbins, Erec  |d 50000  |e 50000PS1263866867  |k 0/50000/  |p 11 
998 |g 1065025017  |a Sundermann, Tom R.  |m 1065025017:Sundermann, Tom R.  |d 910000  |d 912100  |d 50000  |e 910000PS1065025017  |e 912100PS1065025017  |e 50000PS1065025017  |k 0/910000/  |k 1/910000/912100/  |k 0/50000/  |p 8 
999 |a KXP-PPN1908744073  |e 4615179413 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"15 May 202"}],"relHost":[{"note":["Gesehen am 27.07.2020","Ungezählte Beil.: Supplement"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["306710862"],"issn":["1879-3169"],"zdb":["1500784-4"]},"origin":[{"dateIssuedDisp":"1977-","dateIssuedKey":"1977","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]"}],"title":[{"subtitle":"an international journal for the rapid publication of short reports on all aspects of toxicology especially mechanisms of toxicity","title_sort":"Toxicology letters","title":"Toxicology letters"}],"disp":"The fentanyl-specific antibody FenAb024 can shield against carfentanil effectsToxicology letters","recId":"306710862","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1977 -"],"part":{"volume":"396","text":"396(2024) vom: Mai, Seite 1-10","pages":"1-10","extent":"10","year":"2024"}}],"id":{"eki":["1908744073"],"doi":["10.1016/j.toxlet.2024.03.008"]},"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"10 S."}],"person":[{"role":"aut","display":"Urban, Katharina","given":"Katharina","family":"Urban","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Gkeka","given":"Anastasia","display":"Gkeka, Anastasia","role":"aut"},{"given":"Monica","display":"Chandra, Monica","role":"aut","family":"Chandra","roleDisplay":"VerfasserIn"},{"given":"Dennis","role":"aut","display":"Greiner, Dennis","family":"Greiner","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Pollich","given":"Selina","role":"aut","display":"Pollich, Selina"},{"display":"Ruf, Sandra","role":"aut","given":"Sandra","family":"Ruf","roleDisplay":"VerfasserIn"},{"family":"Kelemen","roleDisplay":"VerfasserIn","given":"Yosip","role":"aut","display":"Kelemen, Yosip"},{"role":"aut","display":"Sundermann, Tom R.","given":"Tom R.","roleDisplay":"VerfasserIn","family":"Sundermann"},{"family":"Pravetoni","roleDisplay":"VerfasserIn","display":"Pravetoni, Marco","role":"aut","given":"Marco"},{"roleDisplay":"VerfasserIn","family":"Baehr","role":"aut","display":"Baehr, Carly","given":"Carly"},{"display":"Stebbins, Erec","role":"aut","given":"Erec","roleDisplay":"VerfasserIn","family":"Stebbins"},{"given":"Nina","role":"aut","display":"Papavasiliou, Nina","family":"Papavasiliou","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Verdi","given":"Joseph P.","role":"aut","display":"Verdi, Joseph P."}],"note":["Online verfügbar 6 April 2024, Version des Artikels 13 April 2024","Gesehen am 15.11.2024"],"name":{"displayForm":["Katharina Urban, Anastasia Gkeka, Monica Chandra, Dennis Greiner, Selina Pollich, Sandra Ruf, Yosip Kelemen, Tom Sundermann, Marco Pravetoni, Carly Baehr, C. Erec Stebbins, F. Nina Papavasiliou, Joseph P. Verdi"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1908744073","title":[{"title":"The fentanyl-specific antibody FenAb024 can shield against carfentanil effects","title_sort":"fentanyl-specific antibody FenAb024 can shield against carfentanil effects"}]} 
SRT |a URBANKATHAFENTANYLSP1520